Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
4.917
-0.103 (-2.05%)
Nov 7, 2025, 4:00 PM EST - Market closed
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $187.44 million as of November 7, 2025. Its market cap has decreased by -47.14% in one year.
Market Cap
187.44M
Enterprise Value
163.69M
1-Year Change
-47.14%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $187.44M, a decrease of -62.97%. That is a compound annual growth rate of -18.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 187.44M | -41.44% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | 506.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 838.98B |
| Johnson & Johnson | 450.42B |
| AbbVie | 387.23B |
| UnitedHealth Group | 291.36B |
| AstraZeneca | 251.76B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.24B |
| Thermo Fisher Scientific | 212.97B |